Besides being a diagnostic tool, determination of αFP has also been used to evaluate the response to treatment and, moreover, to detect recurrences[10,21]; other studies have demonstrated that elevated levels of αFP are an independent risk factor for the development of HCC in patients with LC[5,6]. Here, AFP is linked to laryngotracheoesophageal cleft.